257 related articles for article (PubMed ID: 31474422)
21. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the effect of methotrexate on the rate of renal fibrosis by elastography and fibrosis-related gene expression.
Wang Z; Ab Hamid S; Jiang Y; Shang X; Fu Z; Zhao Q; Ab Hamid S
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(6):291-297. PubMed ID: 35818184
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
Frankowski M; Świerkot J; Gomułkiewicz M; Korman L; Skoczyńska M; Starba A
Rheumatol Int; 2022 Apr; 42(4):631-638. PubMed ID: 34870735
[TBL] [Abstract][Full Text] [Related]
24. Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function.
Park JS; Park MC; Park YB; Lee SK; Lee SW
Clin Rheumatol; 2014; 33(10):1415-23. PubMed ID: 24941927
[TBL] [Abstract][Full Text] [Related]
25. Using FibroScan to Assess for the Development of Liver Fibrosis in Patients With Arthritis on Methotrexate: A Single-center Experience.
Darabian S; Wade JP; Kur J; Wade SD; Sayre EC; Badii M
J Rheumatol; 2022 Jun; 49(6):558-565. PubMed ID: 35293340
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and risk factors for liver fibrosis detected by transient elastography or shear wave elastography in inflammatory arthritis: a systematic review.
Rouhi A; Hazlewood G; Shaheen AA; Swain MG; Barber CEH
Clin Exp Rheumatol; 2017; 35(6):1029-1036. PubMed ID: 28598786
[TBL] [Abstract][Full Text] [Related]
27. The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis.
Park HJ; Park MC; Park YB; Lee SK; Lee SW
Rheumatol Int; 2014 Jun; 34(6):833-40. PubMed ID: 24362788
[TBL] [Abstract][Full Text] [Related]
28. Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.
Emery P; Bingham CO; Burmester GR; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; Arendt C; Mountian I; Purcaru O; Tatla D; VanLunen B; Weinblatt ME
Ann Rheum Dis; 2017 Jan; 76(1):96-104. PubMed ID: 27165179
[TBL] [Abstract][Full Text] [Related]
29. Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study.
Dubey L; Chatterjee S; Ghosh A
Indian J Pharmacol; 2016; 48(5):591-594. PubMed ID: 27721549
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
31. Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
Slouma M; Lahmar W; Mohamed G; Dhrif O; Dhahri R; Bellali H; Gharsallah I; Ebdelli N
Clin Rheumatol; 2024 Mar; 43(3):929-938. PubMed ID: 38159207
[TBL] [Abstract][Full Text] [Related]
32. Oral events related to low-dose methotrexate in rheumatoid arthritis patients.
Pedrazas CH; Azevedo MN; Torres SR
Braz Oral Res; 2010; 24(3):368-73. PubMed ID: 20877977
[TBL] [Abstract][Full Text] [Related]
33. Genotoxicity assessment using micronuclei assay in rheumatoid arthritis patients.
Ramos-Remus C; Dorazco-Barragan G; Aceves-Avila FJ; Alcaraz-Lopez F; Fuentes-Ramirez F; Michel-Diaz J; Torres-Bugarin O; Ventura-Aguilar A; Zuñiga-González G
Clin Exp Rheumatol; 2002; 20(2):208-12. PubMed ID: 12051400
[TBL] [Abstract][Full Text] [Related]
34. The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis.
Bjorkman DJ; Boschert M; Tolman KG; Clegg DO; Ward JR
Arthritis Rheum; 1993 Dec; 36(12):1697-701. PubMed ID: 8250989
[TBL] [Abstract][Full Text] [Related]
35. Assessment of liver fibrosis markers in people with rheumatoid arthritis on methotrexate.
Olsson-White DA; Olynyk JK; Ayonrinde OT; Paramalingam S; Keen HI
Intern Med J; 2022 Apr; 52(4):566-573. PubMed ID: 33135387
[TBL] [Abstract][Full Text] [Related]
36. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
[TBL] [Abstract][Full Text] [Related]
37. Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients.
Kameda T; Dobashi H; Miyatake N; Inoo M; Onishi I; Kurata N; Mitsunaka H; Kawakami K; Fukumoto T; Susaki K; Izumikawa M; Nakashima S; Shimada H; Takeuchi Y; Haba R; Mano S; Onishi H; Imataki O; Matsunaga T
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1302-9. PubMed ID: 24515570
[TBL] [Abstract][Full Text] [Related]
38. The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): a masked and controlled study.
Ince A; Yazici Y; Hamuryudan V; Yazici H
Clin Rheumatol; 1996 Sep; 15(5):491-4. PubMed ID: 8894364
[TBL] [Abstract][Full Text] [Related]
39. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
Gilani ST; Khan DA; Khan FA; Ahmed M
J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
[TBL] [Abstract][Full Text] [Related]
40. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
